General Information
Revision date
2025-04-23
Product name
Chloroform-d (containing 1wt% TMS) 99.6atom%D (stabilized with Silver chip)
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H331, H336, H351, H361, H370, H372, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H331 Toxic if inhaled. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H370 Causes damage to organs (Liver, Respiratory system, Car- dio-vascular system, Kidney). H372 Causes damage to organs (Liver, Respiratory system, Kid- ney, Central nervous system) through prolonged or repeated expo- sure. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P260 Do not breathe mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response
P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P391 Collect spillage.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Hazardous Ingredients
Chloroform-d
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher
